Updated: HARVONI & SOVALDI now covered by BC PHARMACARE!!

HARVONI and SOVALDI ACCESS in CANADA, UPDATES as of March 26 (for original Press Release scroll to page bottom) British Columbia UPDATE on SOVALDI/HARVONI TREATMENT CRITERA and ACCESS as of March 26: BC PharmaCare Listing Criteria: http://www.health.gov.bc.ca/pharmacare/sa/criteria/restricted/ledipasvir-sofosbuvir.html BC PharmaCare Information for Prescribers – Sofosbuvir-ledipasvir (Harvoni™) for the treatment of chronic hepatitis C infection g

First interferon-free combo approved by USA’s FDA today!

We are happy to announce the beginning of interferon-free hepatitis C treatment in the USA, ledipasvir plus sofosbuvir (tradename HARVONI). We hope to hear this news in Canada soon, but also hope somehow the people who need it will be able to afford it. Description of their Patient Support Program is interesting as it may be a template for what we will see later in Canada. We quote entire article below. Source is: http://finance.yahoo.com/news/u-food-dru...

Sofosbuvir & Ledipasvir price pact for low income countries announced by Gilead

Gilead signs hepatitis C drug (sofosbuvir - SOVALDI and ledipasvir) pact to make treatment available in low income countries (Reuters, Sept. 15, 2014) "U.S. drugmaker Gilead Sciences Inc GILD.O has licensed its hepatitis C drug Sovaldi to seven India-based drugmakers that will sell far cheaper versions of the $1,000-a-pill medicine in 91 developing nations...Gilead said it would also launch its own branded Sovaldi in India at a price of $300 a month. The...

PDF of WEBINAR about SOFOSBUVIR and LEDIPASVIR COMBO – Dr. Paul Marotta, Sept. 8, 2014

On Sept. 8, 2014, Dr. Paul Marotta of London Health Sciences Centre, presented "Transformation of HCV Management: The IFN-free Era". To access a PDF of this highly-informative and "up-to-the-minute" presentation, click HERE: DrPaulMarotta_20140908_HCV_Treatment_Presentation. Many thanks, Dr. Marotta, for generously sharing these excellent materials with HepCBC's online members.

URGENT REQUEST for patient input into INTERFERON-FREE HCV drug combo: sofosbuvir+ledipasvir

We've been asked by CADTH* to do a Patient Group Review of the new INTERFERON-FREE drug combo sofosbuvir and ledipasvir (also known as SOVALDI and GS-5885) for Chronic Hepatitis C, developed by Gilead Sciences. We urgently request input from individual HCV+ people (both those who have and have not tried this drug combination, any genotype). For background info see http://hepcbc.ca/contribute-sofosbuvir-ledipasvir-submission-cadth/. For the actual que

Sofosbuvir and Ledipasvir, a new COMBO Hepatitis C treatment

HCV Advocate in the USA has just published an excellent fact sheet on the new hepatitis C combo from Gilead, sofosbuvir (SOVALDI) and ledipasvir for genotype 1 only.  Note ledipasvir alone, or in this or any other combination, is still unavailable in Canada, except in an approved clinical trial. Read factsheet:http://www.hcvadvocate.org/hepatitis/factsheets_pdf/Phase_3_Genotype_1_SOF-LDV.pdf